bioRxiv · 10.1101/2023.09.14.557519
OmicsPharLeuDB: an integrative database for mining pharmacogenomic data in acute lymphoblastic leukemia
Abstract
Leukemia is one of the most common hematological malignancies in children. Recent cancer pharmacogenomic studies profiled large panels of cell lines against hundreds of approved drugs and experimental chemical compounds. However, until now, no comprehensive databases have been specifically designed for leukemia. Therefore, we have developed OmicsPharLeuDB (mugpeng.shinyapps.io/leu_web_english_peng_v2/), a database that includes the largest published studies investigating the viability response of human leukemia cell lines to chemical compound treatment, and the association between drug sensitivity and multi-omics, and also provides a user-friendly interactive website allowing the user to assess drug sensitivity data from a different platform and find the potential relationship between drugs and omics.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Peng, Y. Z.. 2023-09-16. OmicsPharLeuDB: an integrative database for mining pharmacogenomic data in acute lymphoblastic leukemia. https://doi.org/10.1101/2023.09.14.557519
Cite the original work for its findings. Save a collection to share your selection of sources.